Anthem Biosciences IPO: Rs 3,395 crore IPO to open on July 14
About Anthem Biosciences IPO
The IPO is an Offer for Sale (OFS) and comprises stake sale aggregating up to Rs 350 crores each by Ganesh Sambasivam and K Ravindra Chandrappa who are promoter selling shareholders. Up to Rs 1,325 crores will be offloaded by Viridity Tone LLP and up to Rs 320 crores by Portsmouth Technologies LLC (Investor Selling Shareholders).
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Free P2,000 GCash eGift
UnionBank Credit Card
Apply Now
Undo
It also includes stake sales of Rs 320 crores each by Malay J Barua, Rupesh N Kinekar and Satish Sharma, up to Rs 80 crore by Prakash Kariabettan and up to Rs 10 crore by K Ramakrishnan.
About Anthem Biosciences
Anthem's business comprises Contract Research, Development and Manufacturing Organization (CRDMO) services and the manufacture and sale of specialty ingredients. It offers a comprehensive, integrated and highly customizable range of CRDMO services across the New Chemical Entity (NCE) and New Biological Entity (NBE) lifecycles.
The company claims to have a strong presence across various modalities, such as RNAi, ADC, peptides, lipids and oligonucleotides, and manufacturing techniques, such as flow chemistry, enzymatic processes, biocatalysis and fermentation, offering a broad range of technology capabilities for drug development.
It also manufactures and sells complex specialized fermentation-based Active Pharmaceutical Ingredients (APIs), including probiotics, enzymes, peptides, nutritional actives, vitamin analogues and biosimilars.
Live Events
Ajay Bhardwaj (Chairman, MD & CEO), Ganesh Sambasivam (Whole-time Director and Chief Scientific Officer), K Ravindra Chandrappa (Whole-time Director and Chief Operating Officer) and Ishaan Bhardwaj (Vice President) are the Promoters of the company.
The company, which was incorporated in 2006, has two operational manufacturing facilities in India, Unit I (Bommassandra) and Unit II (Harohalli), both in Karnataka, with an aggregate annual custom synthesis capacity of 270 kL and fermentation capacity of 142 kL, as of March 31, 2025.
According to the RHP, the company is in the process of expanding its custom synthesis capacity at Unit II (Harohalli) by 130 kL as well as expanding its custom synthesis capacity by 25kL and fermentation capacity by 40kL by constructing Unit III (Neoanthem Lifesciences Private Limited, wholly-owned Subsidiary), both expected to be fully operational by the first half of Fiscal 2026.
Post-expansion activities, the aggregate annual custom synthesis capacity and fermentation capacity is expected to increase to 425 kL and 182 kL, respectively. The fermentation capacity of 182 kL is expected to be more than six times the capacity of the second largest player in this industry, according to the F&S Report.
Anthem Biosciences financials
Its revenue from operations increased by 30% to Rs 1,844 crores in FY25 from Rs 1,419 crores in FY24. The PAT for the year ended March 31, 2025 was Rs 451 crores, a jump of 22.86% over FY24.
Sai Life Sciences Limited,
Syngene International Limited
,
Cohance Lifesciences Limited
, (Formerly Suven Pharmaceuticals) and Divi's Laboratories Limited are the listed peers of Anthem Biosciences, as per its RHP.
Anthem Biosciences lead managers
The Book Running Lead Managers to the offer are
JM Financial Limited
, Citigroup Global Markets India Private Limited, J.P. Morgan India Private Limited and Nomura Financial Advisory and Securities (India) Private Limited.
The equity shares are proposed to be listed on BSE and NSE.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
17 minutes ago
- Time of India
VC fund Yali Capital closes first deeptech fund at Rs 893 crore; exceeds target
The fund has exceeded the target corpus of Rs 810 crore, including a greenshoe option of Rs 310 crore. Infosys, Qualcomm Ventures, Tata AIG, DPIIT Fund of Funds for Startups (managed by SIDBI), Self-Reliant India Fund, and Evolvence also participated in the fundraise. The money will be invested across early- and late-stage companies in the deeptech space, including semiconductors, AI, robotics, genomics, aerospace/surveillance, and smart manufacturing. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Deeptech-focussed venture capital fund Yali Capital on Friday announced the final close of its maiden fund at Rs 893 crore (around $104 million).The fund, launched in July last year, has exceeded the target corpus of Rs 810 crore, which included a greenshoe option of Rs 310 crore. This is a provision that allows a fund to raise more capital than originally targeted in case of higher-than-expected this fund, Yali plans to invest across early- and late-stage companies with a focus on deeptech sectors, including semiconductors, artificial intelligence (AI), robotics , genomics, aerospace/surveillance, and smart has already deployed capital in five companies, including fabless chip design company C2I Semiconductor, healthcare startup 4basecare, and robotics startup Perceptyne. It plans to invest in three more companies by the end of this fund is helmed by Ganapathy Subramaniam, a former partner at Celesta Capital, and Mathew Cyriac, former private equity (PE) co-head for Blackstone in India and executive chairman of PE firm Florintree Capital Partners.'Nearly a third of our fund will be invested in late-stage deep tech companies. India has a real opportunity to build globally competitive public companies in this space,' said Bengaluru-based fund is a Securities and Exchange Board of India (Sebi)-approved Category 2 Alternate Investment Fund (AIF). Infosys , Qualcomm Ventures, Tata AIG, DPIIT Fund of Funds for Startups (managed by SIDBI), Self-Reliant India (SRI) Fund, and Evolvence are among other investors who participated in the fundraise.'We firmly believe in India's deeptech potential and are committed to backing visionary founders with patient capital,' said Subramaniam. In June, ET had reported that Indian deeptech funds are raising fresh funds to step up investments as more companies come into this space on the back of government initiatives, a favourable geopolitical landscape, and rapid technological in deeptech companies doubled in the first four months of 2025 to $324 million across 35 deals against $156 million from 21 deals in the same period last year, as per data from Venture Intelligence.
India.com
17 minutes ago
- India.com
EPFO alert: New rule makes family eligible for Rs 50000 payout if PF holder dies even if Death balance in fund is less than…
Home Business EPFO alert: New rule makes family eligible for Rs 50000 payout if PF holder dies even if Death balance in fund is less than… EPFO alert: New rule makes family eligible for Rs 50000 payout if PF holder dies even if Death balance in fund is less than… EPFO's new move is seen as a big step forward in strengthening the social security net for employees and their dependents. (File/Representational) The Ministry of Labour and Employment has notified the Employees' Deposit-Linked Insurance (Amendment) Scheme, 2025, has updated the policy in which they are easing the eligibility criteria for insurance benefits under the EPFO. As per the new notification, in the unfortunate event of an EPF member's death, a minimum assurance benefit of Rs 50,000 will now be payable to the family, even if the employee's average provident fund balance is less than Rs 50,000. This will be applicable to members of both regular EPF and those covered under exempted provident funds under Section 17 of the EPF Act. EPFO New Rules: The benefit applies even if the employee dies during the preceding 12 months or still in service. To qualify for the benefit, a continuous service of 12 months was required. However, the EPFO has clarified that a gap of up to 60 days between two periods of employment will not break continuity and multiple services will be counted as one. If a member dies within six months of the last PF contribution while still on the employer's payroll, the family is still eligible for the Rs 50000 benefit under the amended scheme. EPFO Old Rule VS New Rule Earlier, families of employees who passed away within a year of joining were not eligible for EDLI insurance benefits. After this amendment, the scheme now will give minimum financial support of Rs 50,000 to the bereaved families and much-needed relief during difficult times. For breaking news and live news updates, like us on Facebook or follow us on Twitter and Instagram. Read more on Latest Business News on
New Indian Express
17 minutes ago
- New Indian Express
India announces Rs 4,850 crore Line of Credit to Maldives
MALE: India is proud to be the most trusted friend of the Maldives, Prime Minister Narendra Modi said on Friday after announcing a Rs 4,850 crore line of credit to the island nation. Modi made the remarks after holding wide-ranging talks with Maldivian President Mohamed Muizzu, focusing on consolidating cooperation in areas of trade, defence and infrastructure. The prime minister's visit marked a major turnaround in India-Maldives ties after a spell of unease. Modi also announced that the two countries will work towards finalising a bilateral investment treaty and that negotiations for a free trade pact have already started. The Maldives holds an important place in India's "Neighbourhood First" policy and MAHASAGAR (Mutual and Holistic Advancement for Security and Growth Across Regions) vision, the prime minister said. Modi said India has decided to provide a line of credit of USD 565 million (Rs 4,850 crore) to the Maldives. Mutual cooperation in the field of defence and security is a testament to mutual trust, he said. India will always support the Maldives to strengthen its defence capabilities, he added. Modi landed in Male this morning to a warm welcome with Muizzu and a number of top ministers of his government receiving the prime minister at the Velena international airport, reflecting the importance Male attached to the trip.
